Literature DB >> 9604971

Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation.

R K Chang1, M Alzona, J Alejos, K Jue, S V McDiarmid.   

Abstract

Although the cardiac effects of tacrolimus (FK506) have not been well documented, clinical cases of children on FK506 who developed hypertrophic obstructive cardiomyopathy have been reported. We report 2 cases of marked concentric hypertrophy of the left ventricular myocardium found at autospy in children on FK506.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9604971     DOI： 10.1016/s0002-9149(98)00126-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  4 in total

1.  Reverse ventricular remodeling and improved ventricular compliance after heart transplantation in infants and young children.

Authors:  Kanwal M Farooqi; Leo Lopez; Robert H Pass; Daphne T Hsu; Jacqueline M Lamour
Journal:  Pediatr Cardiol       Date:  2014-02-09       Impact factor: 1.655

2.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 3.  Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.

Authors:  G V Mazariegos; A A Salzedas; A Jain; J Reyes
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients.

Authors:  Nosheen Reza; Alejandro De Feria; Teresa Wang; Jessica L Chowns; Lily Hoffman-Andrews; Jessica Kim; Nicole Hornsby; Amy Marzolf; Pavan Atluri; Howard C Herrmann; Anjali Tiku Owens
Journal:  Transplant Direct       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.